Accessibility Menu
Cardio Diagnostics logo

Cardio Diagnostics

(NASDAQ) CDIO

Current Price$2.02
Market Cap$5.98M
Since IPO (2022)-99%
5 YearN/A
1 Year-38%
1 Month+14%

Cardio Diagnostics Financials at a Glance

Market Cap

$5.98M

Revenue (TTM)

$16.57K

Net Income (TTM)

-$6.65M

EPS (TTM)

-$3.38

P/E Ratio

-0.60

Dividend

$0.00

Beta (Volatility)

1.15 (Average)

Price

$2.02

Volume

440

Open

$2.05

Previous Close

$2.02

Daily Range

$2.01 - $2.12

52-Week Range

$0.97 - $7.91

Estimated Earnings Date

Aug 13, 2026

CDIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardio Diagnostics

Industry

Biotechnology

Employees

15

CEO

Meeshanthini V. Dogan, PhD

Headquarters

Chicago, IL 60642, US

CDIO Financials

Key Financial Metrics (TTM)

Gross Margin

-471.40%

Operating Margin

-40074.58%

Net Income Margin

-40152.50%

Return on Equity

-78.82%

Return on Capital

-84.55%

Return on Assets

-69.58%

Earnings Yield

-1.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.98M

Shares Outstanding

2.96M

Volume

440

Avg. Volume

72.64K

Financials (TTM)

Gross Profit

-$78.09K

Operating Income

-$6.64M

EBITDA

-$6.27M

Operating Cash Flow

-$5.89M

Capital Expenditure

-$200.31K

Free Cash Flow

-$6.09M

Cash & ST Invst.

$7.08M

Total Debt

$533.00K

Cardio Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.68K

+185.1%

Gross Profit

-$91.97K

-9884.3%

Gross Margin

-34.32%

N/A

Market Cap

$5.98M

N/A

Market Cap/Employee

$459.85K

N/A

Employees

13

N/A

Net Income

-$1.79M

-9.4%

EBITDA

-$1.69M

-12.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$7.08M

-27.0%

Total Debt

$533.00K

-11.9%

Accounts Receivable

$4.27K

-55.3%

Inventory

$0.00

N/A

Long Term Debt

$164.53K

-54.8%

Short Term Debt

$368.47K

+53.1%

Return on Assets

-69.58%

N/A

Return on Invested Capital

-73.21%

N/A

Free Cash Flow

-$1.56M

-8.0%

Operating Cash Flow

-$1.56M

-11.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCDABioCardia, Inc.
$1.09+2.83%
RADXRadiopharm Theranostics Limited
$4.33+4.59%
CELZCreative Medical Technology Holdings, Inc.
$2.00+0.00%
TCRTAlaunos Therapeutics, Inc.
$2.07-3.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBITiShares Bitcoin Trust
$33.52-0.01%
AAPLApple
$274.30-0.06%
INTCIntel
$132.51+0.01%
NVDANvidia
$195.29-0.02%

Questions About CDIO

What is the current price of Cardio Diagnostics?

Cardio Diagnostics is trading at $2.02 per share.

What is the 52-week range for Cardio Diagnostics?

Over the past 52 weeks, Cardio Diagnostics has traded between $0.97 and $7.91.

How much debt does Cardio Diagnostics have?

As of the most recent reporting period, Cardio Diagnostics reported total debt of $533.00K.

How much cash does Cardio Diagnostics have on hand?

Cardio Diagnostics reported $7.08M in cash and cash equivalents in its most recent financial results.

What is Cardio Diagnostics’s dividend yield?

Cardio Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.